Sidley Austin represented Stanley Capital Partners in the transaction, and Winston & Strawn represented SePRO and Excellere Partners. Latham & Watkins represented Goldman Sachs Alternatives as...
Stanley Capital Partners’ Majority Investment in SePRO
Stanley Capital Partners’ Investment in Roboyo
Sidley represented Stanley Capital Partners. Stanley Capital Partners, the specialist healthcare and resource efficiency private equity investor, has completed its strategic investment in Roboyo, the world’s...
Qinecsa’s Acquisition of Commonwealth Informatics
Foot Anstey LLP advised Stanley Capital Partners (SCP) on the deal. Qinecsa, a leading provider of pharmacovigilance services and technologies, is home to 2600+ scientific, medical...
Stanley Capital Partners’ Acquisition of Laboratoire XO
Willkie and Foot Anstey represented Stanley Capital Partners in the transaction. Stanley Capital Partners announced its acquisition of a majority stake in French pharmaceutical group Laboratoire...
Stanley Capital and DSS’ Acquisition of MyMeds&Me
Stephenson Harwood LLP has advised Stanley Capital Partners LLP and Drug Safety and Pharmacovigilance Services Solutions on the deal. Stanley Capital Partners LLP (SCP) acquired through...
Stanley Capital Partners’ Acquisition of Clario’s Drug Safety Solutions
Willkie represented Stanley Capital Partners, while Latham & Watkins advised Astorg, Nordic Capital, and Portfolio Company Clario on the deal. The parties have announced the divestiture...